Statement re Scisys

Microgen PLC 11 April 2008 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION For immediate release 11 April 2008 Microgen plc ('Microgen' or the 'Company') Statement regarding Scisys plc ('Scisys') The Board of Microgen notes the recent rise in the share price of Scisys and the associated press speculation. Microgen confirms that on 3 April 2008, it acquired 3,206,081 shares in Scisys at 32 pence per share and on 7 April 2008 acquired an additional 464,605 shares at 36.5 pence per share. In total therefore Microgen holds 3,670,686 shares representing approximately 12.89% of the issued share capital of Scisys. Microgen and Scisys have collaborated in a number of business areas and this operational relationship continues. An informal meeting has been held between Microgen and Scisys and the Board of Microgen continues to consider its options, which may or may not include an offer for Scisys. This announcement does not amount to a firm intention to make an offer under Rule 2.5 of the City Code on Takeovers and Mergers and, as such, there can be no certainty that any offer will be made nor as to the terms and pre-conditions on which any such offer may be made. A further announcement may be made, if and when appropriate. Enquiries: Microgen plc Tel: 01252 772300 Martyn Ratcliffe Philip Wood Arbuthnot Securities Limited Tel: 020 7012 2000 Tom Griffiths Alasdair Younie Financial Dynamics Tel: 020 7831 3113 Giles Sanderson Haya Chelhot Dealing Disclosure Requirements Under the provisions of Rule 8.3 of the Takeover Code (the 'Code'), if any person is, or becomes, 'interested' (directly or indirectly) in 1% or more of any class of 'relevant securities' of Microgen or of Scisys, all 'dealings' in any 'relevant securities' of that company (including by means of an option in respect of, or a derivative referenced to, any such 'relevant securities') must be publicly disclosed by no later than 3.30 p.m. (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the 'offer period' otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an 'interest' in 'relevant securities' of Microgen or Scisys, they will be deemed to be a single person for the purpose of Rule 8.3. Under the provisions of Rule 8.1 of the Code, all 'dealings' in 'relevant securities' of Microgen or Scisys by Microgen or Scisys, or by any of their respective 'associates', must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction. A disclosure table, giving details of the companies in whose 'relevant securities' 'dealings' should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk. 'Interests in securities' arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an 'interest' by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities. Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a 'dealing' under Rule 8, you should consult the Panel. In accordance with Rule 2.10 of the Code, Microgen confirms that, as at the close of business on 10 April 2008, it had in issue 102,882,276 ordinary shares of 5p each. The ISIN reference for the Ordinary Shares is GB0005869531. This information is provided by RNS The company news service from the London Stock Exchange RSAAR
UK 100

Latest directors dealings